全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

NEK6在HepG2细胞中的定位及其在肝癌中的表达和临床意义
The Localization of NEK6 in HepG2 Cell Line and Its Expression and Clinical Significance in HCC

DOI: 10.12677/WJCR.2021.113009, PP. 67-75

Keywords: NEK6,亚细胞定位,肝细胞肝癌
NEK6
, Subcellular Localization, Hepatocellular Carcinoma

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:检测NEK6在HepG2细胞中的定位,肝细胞肝癌组织与正常肝脏组织中的表达水平,分析其与临床病理学资料间的关系。方法:在HepG2细胞中转染pMCV-Nek6-Myc和pMCV-Nek6-Flag,应用间接免疫荧光法测定NEK6在HepG2细胞中的定位;应用RT-qPCR法检测47例肝细胞肝癌(HCC)组织与相应远癌旁组织(>1 cm)中NEK6 mRNA的表达水平;应用Western blot法检测该47例肝细胞肝癌组织与相应正常肝组织中NEK6蛋白的表达水平。收集并统计该组患者的临床病理学资料,包括性别、年龄、肿瘤大小、肿瘤数量(单个/多个)、血清AFP水平(≥400 ng/ml或<400 ng/ml)、Edmondson分级、纤维包膜、微血管侵犯(microvascular invasion, MVI)等,分析NEK6 mRNA表达水平与各临床病理特点的关系。配对样本应用配对t检验,单因素分析用卡方检验,多因素分析用二元Logistic回归分析,以P < 0.05认为结果有统计学意义。结果:免疫荧光实验显示,NEK6主要定位于HepG2细胞的细胞核中,在细胞质中也有少量存在;RT-qPCR结果显示,NEK6 mRNA在HCC中的表达量为(1.405 ± 0.472),显著高于正常肝组织中的表达量(1.133 ± 0.474),差异有统计学意义(t = 3.143, P = 0.0029);Western blot结果显示,NEK6蛋白在HCC中的表达量为(1.031 ± 0.193),显著高于正常肝组织中的表达量(0.906 ± 0.182),差异有统计学意义(t = 3.464, P = 0.0012)。结论:NEK6主要存在于HepG2细胞的细胞核中,在肝细胞肝癌中表达上调,微血管侵犯是Nek6表达水平的独立相关因素,可能作为肝癌预后不良的判断指标之一。
Objective: To detect the localization of NEK6 in HepG2 cells, the expression level of hepatocellular carcinoma tissues and normal liver tissues, and to analyze the relationship between NEK6 and clinicopathological data. Methods: HepG2 cells were transfected with pMCV-Nek6-Myc and pMCV-Nek6-Flag, and the localization of NEK6 in HepG2 cells was determined by indirect immunofluorescence method. RT-qPCR was used to detect the expression level of NEK6 mRNA in 47 cases of hepatocellular carcinoma (HCC) tissues and corresponding distant adjacent tissues (>1 cm). Western blot was used to detect the NEK6 protein expression levels in the 47 cases of hepatocellular carcinoma tissues and corresponding normal liver tissues. The clinical pathological data of this group of patients were collected and counted, including gender, age, tumor size, tumor number (single/multiple), serum AFP level (≥400 ng/ml or <400 ng/ml), Edmondson grade, fiber envelope , Microvascular invasion (microvascular invasion MVI), etc., to analyze the relationship between NEK6 mRNA expression level and various clinicopathological characteristics. Paired samples were tested by paired t test, chi-square test was used for univariate analysis, and binary logistic regression analysis was used for multivariate analysis. The results were considered statistically significant at P < 0.05. Results: Immunofluorescence experiments showed that NEK6 was mainly located in the nucleus of HepG2 cells, and a small amount in the cytoplasm; RT-qPCR results showed that the expression of NEK6 mRNA in HCC was (1.405 ± 0.472), which was significantly higher than that of normal liver tissue: the expression level in HCC (1.133 ± 0.474); the difference was statistically significant (t = 3.143, P = 0.0029); Western

References

[1]  Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
[2]  Petrick, J.L., Florio, A.A., Znaor, A., et al. (2020) International Trends in Hepatocellular Carcinoma Incidence, 1978-2012. International Journal of Cancer, 147, 317-330.
https://doi.org/10.1002/ijc.32723
[3]  Osmani, S.A., May, G.S. and Morris, N.R. (1987) Regulation of the mRNA Levels of nimA, a Gene Required for the G2-M Transition in Aspergillus nidulans. Journal of Cell Biology, 104, 1495-504.
https://doi.org/10.1083/jcb.104.6.1495
[4]  李梅章, 褚嘉祐, 杨昭庆, 等. 一个NEK基因家族新成员的克隆和鉴定[J]. 遗传, 2001(2): 97-102.
[5]  Adib, R., Montgomery, J.M., Atherton, J., et al. (2019) Mitotic Phosphorylation by NEK6 and NEK7 Reduces the Microtubule Affinity of EML4 to Promote Chromosome Congression. Science Signaling, 12, eaaw2939.
https://doi.org/10.1126/scisignal.aaw2939
[6]  Jee, H.J., Kim, A.J., Song, N., et al. (2010) Nek6 Overexpression Antagonizes p53-Induced Senescence in Human Cancer Cells. Cell Cycle, 9, 4703-4710.
https://doi.org/10.4161/cc.9.23.14059
[7]  Villanueva, A. (2019) Hepatocellular Carcinoma. The New England Journal of Medicine, 380, 1450-1462.
https://doi.org/10.1056/NEJMra1713263
[8]  Craig, A.J., von Felden, J., Garcia-Lezana, T., et al. (2020) Tumour Evolution in Hepatocellular Carcinoma. Nature Reviews Gastroenterology & Hepatology, 17, 139-152.
https://doi.org/10.1038/s41575-019-0229-4
[9]  Huang, D.Q., El-Serag, H.B. and Loomba, R. (2021) Global Epidemiology of NAFLD-Related HCC: Trends, Predictions, Risk Factors and Prevention. Nature Reviews Gastroenterology & Hepatology, 18, 223-238.
https://doi.org/10.1038/s41575-020-00381-6
[10]  Giannini, E.G. (2021) Improving Prognosis of Patients with Very Early Hepatocellular Carcinoma: How Far Are We Going? Digestive and Liver Disease, 53, 143-145.
https://doi.org/10.1016/j.dld.2020.11.006
[11]  de Cárcer, G., Pérez de Castro, I. and Malumbres, M. (2007) Targeting Cell Cycle Kinases for Cancer Therapy. Current Medicinal Chemistry, 14, 969-985.
https://doi.org/10.2174/092986707780362925
[12]  Malumbres, M. and Barbacid, M. (2007) Cell Cycle Kinases in Cancer. Current Opinion in Genetics and Development, 17, 60-65.
https://doi.org/10.1016/j.gde.2006.12.008
[13]  Belham, C., Roig, J., Caldwell, J.A., et al. (2003) A Mitotic Cascade of NIMA Family Kinases. Nercc1/Nek9 Activates the Nek6 and Nek7 Kinases. Journal of Biological Chemistry, 278, 34897-34909.
https://doi.org/10.1074/jbc.M303663200
[14]  O’Connell, M.J., Krien, M.J. and Hunter, T. (2003) Never Say Never. The NIMA-Related Protein Kinases in Mitotic Control. Trends in Cell Biology, 13, 221-228.
https://doi.org/10.1016/S0962-8924(03)00056-4
[15]  Bertran, M.T., Sdelci, S., Regué, L., et al. (2011) Nek9 Is a Plk1-Activated Kinase That Controls Early Centrosome Separation through Nek6/7 and Eg5. The EMBO Journal, 30, 2634-2647.
https://doi.org/10.1038/emboj.2011.179
[16]  O’Regan, L., Sampson, J., Richards, M.W., Knebel, A., Roth, D., Hood, F.E., Straube, A., Royle, S.J., Bayliss, R. and Fry, A.M. (2015) Hsp72 Is Targeted to the Mitotic Spindle by Nek6 to Promote K-Fiber Assembly and Mitotic Progression. Journal of Cell Biology, 209, 349-358.
https://doi.org/10.1083/jcb.201409151
[17]  Rapley, J., Nicolàs, M., Groen, A., et al. (2008) The NIMA-Family Kinase Nek6 Phosphorylates the Kinesin Eg5 at a Novel Site Necessary for Mitotic Spindle Formation. Journal of Cell Science, 121, 3912-3921.
https://doi.org/10.1242/jcs.035360
[18]  Choudhury, A.D., Schinzel, A.C., Cotter, M.B., et al. (2017) Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6. Cancer Research, 77, 753-765.
https://doi.org/10.1158/0008-5472.CAN-16-0455
[19]  He, Z., Ni, X., Xia, L., et al. (2018) Overexpression of NIMA-Related Kinase 6 (NEK6) Contributes to Malignant Growth and Dismal Prognosis in Human Breast Cancer. Pathology—Research and Practice, 214, 1648-1654.
https://doi.org/10.1016/j.prp.2018.07.030

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133